{
  "trial_id": "NCT02985866",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of diabetes, HbA1c level, insulin pump usage duration, type of rapid-acting insulin used, use of continuous glucose monitoring (CGM), pregnancy status, network connectivity capability, ability to operate study devices, living situation (for participants under 18).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Diabetes duration at randomization (years)",
          "duration of diabetes"
        ],
        [
          "HbA1c at randomization: laboratory",
          "HbA1c level"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Prior CGM use",
        "BMI at enrollment (kg/m2)",
        "C-Peptide at randomization (nmol/L): Laboratory",
        "Diabetes ketoacidosis events in the last 12 months",
        "Severe hypoglycemic events in past 12 months"
      ],
      "remaining_candidate_features": [
        "insulin pump usage duration",
        "type of rapid-acting insulin used",
        "pregnancy status",
        "network connectivity capability",
        "ability to operate study devices",
        "living situation (for participants under 18)"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, HbA1c, Insulin Pump Use Duration, Type of Rapid-Acting Insulin Used,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Diabetes duration at randomization (years)",
          "Duration of Diabetes"
        ],
        [
          "HbA1c at randomization: laboratory",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Prior CGM use",
        "BMI at enrollment (kg/m2)",
        "C-Peptide at randomization (nmol/L): Laboratory",
        "Diabetes ketoacidosis events in the last 12 months",
        "Severe hypoglycemic events in past 12 months"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Insulin Pump Use Duration",
        "Type of Rapid-Acting Insulin Used"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "##Answer:\nAge, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Diagnosis Duration, Insulin Pump Use Duration, HbA1c, BMI, Total Daily Insulin Dose, History of Severe Hypoglycemia,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Diabetes duration at randomization (years)",
          "Diabetes Diagnosis Duration"
        ],
        [
          "Prior CGM use",
          "Insulin Pump Use Duration"
        ],
        [
          "HbA1c at randomization: laboratory",
          "HbA1c"
        ],
        [
          "BMI at enrollment (kg/m2)",
          "BMI"
        ],
        [
          "Severe hypoglycemic events in past 12 months",
          "History of Severe Hypoglycemia"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "C-Peptide at randomization (nmol/L): Laboratory",
        "Diabetes ketoacidosis events in the last 12 months"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Total Daily Insulin Dose"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, duration of type 1 diabetes, insulin pump usage duration, HbA1c level, body mass index (BMI), type of rapid-acting insulin used, frequency of blood glucose monitoring, history of severe hypoglycemia, presence of diabetes-related complications, education level, occupation, living situation (alone or with diabetes care partner).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Diabetes duration at randomization (years)",
          "duration of type 1 diabetes"
        ],
        [
          "Prior CGM use",
          "frequency of blood glucose monitoring"
        ],
        [
          "HbA1c at randomization: laboratory",
          "HbA1c level"
        ],
        [
          "Severe hypoglycemic events in past 12 months",
          "history of severe hypoglycemia"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "BMI at enrollment (kg/m2)",
        "C-Peptide at randomization (nmol/L): Laboratory",
        "Diabetes ketoacidosis events in the last 12 months"
      ],
      "remaining_candidate_features": [
        "insulin pump usage duration",
        "body mass index (BMI)",
        "type of rapid-acting insulin used",
        "presence of diabetes-related complications",
        "education level",
        "occupation",
        "living situation (alone or with diabetes care partner)"
      ]
    }
  }
}